Gerald Lam is a senior associate in Baker McKenzie's Hong Kong Dispute Resolution Practice Group, and specialises in international risk and investigations. He has particular experience in advising multinational clients on global anti-corruption and compliance matters in relation to cross-border investments and operations, including on anti-bribery and corruption, international economic sanctions, AML and financial fraud, with a special focus on the financial services, private equity, life sciences and TMT sectors.
Prior to joining Baker McKenzie, he previously worked for a top global law firm based in Hong Kong.
Representative Legal Matters
Compliance and Regulatory Counselling
- Advised a NYSE-listed global alternative investment fund in relation to sanctions and corruption risks in relation to an investment in a multinational reinsurance company.
- Advised a global private equity firm on international risk in relation to the acquisition of a controlling stake in a leading India-based medical devices company; this is the first unitranche financing for an Asia leveraged buy-out.
- Conducted an anti-corruption and sanctions compliance review and risk assessment of a leading global private equity firm’s investment portfolios in India.
- Advised an investment management firm and the consortium offeror on sanctions and international risk in the proposed privatization of a multinational supply-chain management company listed on the HKSE.
- Providing international risk advice to a NYSE-listed investment management company focusing on the development of digital payments, digital finance and marketing technology platforms.
- Advised a prominent asset investment firm on international anti-corruption and sanctions risks in relation to a controlling investment in an infrastructure investment trust in India.
- Conducted an internal investigation on behalf of a Hong Kong-listed logistics, financial services and engineering company in response to suspected financial misconduct, fraud, and breach of fiduciary duties by directors in Singapore and Hong Kong.
- Conducted an internal investigation into whistle-blower allegations of financial irregularity and fraudulent misconduct in relation to an asset management services platform established by a NY-listed global investment firm.
- Conducted an anti-bribery and internal controls investigation for a prominent global alternative asset investment firm in relation to potential allegations of fraud and misconduct relating to its portfolio investment in Saudi Arabia.
- Conducted multiple anti-bribery, books and records/internal controls investigations for a major U.S.-listed pharmaceutical, medical devices, and consumer goods manufacturer in Indonesia and Japan into allegations involving fabricated documentation; inappropriate interactions with HCPs and government officials; third party distribution risks; and inappropriate involvement in the preparation of an investigator-initiated clinical research scientific protocol.
- Conducted an internal investigation on behalf of a Hong Kong-listed company in response to suspected financial misconduct, fraud, and breach of fiduciary duties by directors.
- Advised a global financial institution in relation to requests for information from the Hong Kong ICAC in connection with a bribery investigation.
- Acted as counsel to a multinational software company in an antitrust investigation before the Hong Kong Competition Commission in relation to allegations of price fixing.
Professional Associations and Memberships
- The Law Society of Hong Kong - Member
- The Canadian Chamber of Commerce in Hong Kong - Member
- McMaster Alumni Association of Hong Kong - Chairman
- Hong Kong (2013)
- Chinese University of Hong Kong (PCLL) (2011)
- Chinese University of Hong Kong (JD) (2010)
- McMaster University (Bachelor of Arts in Political Science) (2006)
- Co-author, "Navigating the Currents of US and PRC Sanctions: Compliance and Best Practice for Financial Institutions," China Law and Practice, May 2021
- Co-author, "INSIGHT: Hong Kong Financial Regulator Can Seize Devices, Access Accounts," Bloomberg Law, April 2020
- Co-author, "A Shift in U.S. FCPA Policy—Should Chinese Companies be Worried?" Bloomberg Law, June 2019
- Co-author, "Anti-corruption due diligence in cross-border transactions," Thomson Reuters, March 2019
- Co-author, “Heads or Tails? Are Europe’s GDPR and China’s Cybersecurity Law Two Sides of the Same Coin?” China Business Law Journal, May 2018